Evidence map›Paper›PMID 22345566›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.

Stephanie A Kazane, Devin Sok, Edward H Cho, Maria Loressa Uson, Peter Kuhn, Peter G Schultz, Vaughn V Smider

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 151 citations in OpenAlex.

  1. Emerging technologies in the spatial proteomics landscape.Analytical and bioanalytical chemistry · 2026
    Review
  2. Article
  3. Review
  4. Comparative Evaluation of Antibody-Oligonucleotide Conjugation Strategies for Multiplexed Imaging Applications.Laboratory investigation; a journal of technical methods and pathology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Introduction of Carbonyl Groups into Antibodies.Molecules (Basel, Switzerland) · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stephanie A KazaneDepartment of Chemistry, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Devin Sok
Edward H Cho
Maria Loressa Uson
Peter Kuhn
Peter G Schultz
Vaughn V Smider
Scripps Research Institute · US

Funding

TopologyU54CA143906 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KUHN, PETER · 2009 to 2014
$10.2M
IN VIVO INCORPORATION OF UNNATURAL AMINO ACIDSR01GM062159 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHULTZ, PETER G · 2001 to 2022
$8.2M
Modular immunoconjugatesRC1EB010745 · NIBIB · SCRIPPS RESEARCH INSTITUTE, THE · PI SMIDER, VAUGHN VASIL · 2009 to 2010
$1000k
CCR NIH HHS 1RC1EBO10745NCI NIH HHS U54 CA143906NCI NIH HHS U54CA143906NIBIB NIH HHS RC1 EB010745NIGMS NIH HHS R01 GM062159NIGMS NIH HHS R01GM062159
6 · The paper itself

Abstract

Antibody conjugates are widely used as diagnostics and imaging reagents. However, many such conjugates suffer losses in sensitivity and specificity due to nonspecific labeling techniques. We have developed methodology to site-specifically conjugate oligonucleotides to antibodies containing a genetically encoded unnatural amino acid with orthogonal chemical reactivity. These oligobody molecules were used in immuno-PCR assays to detect Her2(+) cells with greater sensitivity and specificity than nonspecifically coupled fragments, and can detect extremely rare Her2(+) cells in a complex cellular environment. Such designed antibody-oligonucleotide conjugates should provide sensitive and specific reagents for diagnostics, as well as enable other unique applications based on oligobody building blocks.

Indexed as

AntibodiesCell Line, TumorCell NucleusDNAErb-b2 Receptor Tyrosine KinasesHumansImmune SystemKineticsLeukocytesMicroscopy, FluorescenceNeoplasmsNucleic Acid HybridizationOligonucleotidesPolymerase Chain ReactionSequence Analysis, DNATemperatureAntibodiesDNAErb-b2 Receptor Tyrosine KinasesOligonucleotides

Identifiers

PMID22345566
PMCPMC3309776
OpenAlexW2036233886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.